Expansion and increased survival of natural killer and CD4 T cells expressing the Killer IG-like Receptor KIR3DL2 in spondyloarthritis.

Expansion and increased survival of natural killer and CD4 T cells expressing the Killer IG-like Receptor KIR3DL2 in spondyloarthritis.

Dettagli Bibliografici
Autori principali:	Chan, A, Kollnberger, S, Wedderburn, L, Bowness, P
Natura:	Conference item
Pubblicazione:	2005

Documenti analoghi

Expansion and enhanced survival of natural killer cells expressing the killer immunoglobulin-like receptor KIR3DL2 in spondylarthritis.
di: Chan, A, et al.
Pubblicazione: (2005)

PHENOTYPIC CHARACTERIZATION OF NATURAL KILLER CELLS AND RECEPTORS IN SPONDYLOARTHRITIS
di: Chan, A, et al.
Pubblicazione: (2004)

New perspectives on the ligands and function of the killer cell immunoglobulin-like receptor KIR3DL2 in health and disease.
di: Shaw, J, et al.
Pubblicazione: (2012)

Molecular Characterisation Of The Killer Cell Immunoglobulin-Like Receptor 3DL2 Binding To Aberrant HLA-B27 Heavy Chains In Spondyloarthritis
di: Hatano, H, et al.
Pubblicazione: (2013)

New perspectives on the ligands and function of the killer cell immunoglobulin-like receptor KIR3DL2 in health and disease
di: Jacqueline eShaw, et al.
Pubblicazione: (2012-11-01)

Phenotypic and functional characterisation of natural killer (NK) receptor expressing T lymphocytes in spondyloarthritis
di: Chan, A, et al.
Pubblicazione: (2005)

Natural Killer Cells and Cancer--Regulation by the Killer Cell Ig-like Receptors (KIR)
di: Amanda K. PURDY, et al.
Pubblicazione: (2010-07-01)

The role of HLA-B27 interactions with natural killer receptors in the pathogenesis of spondyloarthritis
di: Kollnberger, S, et al.
Pubblicazione: (2007)

NK Cells Expressing the Inhibitory Killer Immunoglobulin-Like Receptors (iKIR) KIR2DL1, KIR2DL3 and KIR3DL1 Are Less Likely to Be CD16+ than Their iKIR Negative Counterparts.
di: Gamze Isitman, et al.
Pubblicazione: (2016-01-01)

THE ROLE OF HLA-B27 KIR3DL2 INTERACTIONS IN THE PATHOGENESIS OF SPONDYLOARTHRITIS
di: Kollnberger, S, et al.
Pubblicazione: (2012)

Allele imputation for the killer cell immunoglobulin-like receptor KIR3DL1/S1.
di: Genelle F Harrison, et al.
Pubblicazione: (2022-02-01)

Activation-induced killer cell immunoglobulin-like receptor 3DL2 binding to HLA-B27 licenses pathogenic T cell differentiation in spondyloarthritis
di: Ridley, A, et al.
Pubblicazione: (2016)

HLA-B27 and KIR3DL2 Interactions Promote The Differentiation and Survival Of Proinflammatory T Cells In Spondyloarthritis
di: Ridley, A, et al.
Pubblicazione: (2013)

Killer Cell Ig-like Receptors (KIR)-Binding Assay for Tumor Cells
di: Loredana Cifaldi, et al.
Pubblicazione: (2016-09-01)

Interaction between human leukocyte antigen (HLA-C) and killer cell Ig-like receptors (KIR2DL) inhibits the cytotoxicity of natural killer cells in patients with hepatoblastoma
di: Jing-Jie Guo, et al.
Pubblicazione: (2022-11-01)

No association of alleles of the killer immunoglobulin-like receptor gene KIR3DL2 with ankylosing spondylitis
di: Harvey, D, et al.
Pubblicazione: (2008)

Diversity of killer cell immunoglobulin-like receptor (KIR) genotypes and KIR2DL2/3 variants in HCV treatment outcome.
di: Jose Ramón Vidal-Castiñeira, et al.
Pubblicazione: (2014-01-01)

Natural killer cell and synovial fibroblast cross talk - A role in the pathogenesis of spondyloarthritis
di: Chan, A, et al.
Pubblicazione: (2006)

Influence of Interleukin IL-2 and IL-12 + IL-18 on Surface Expression of Immunoglobulin-Like Receptors KIR2DL1, KIR2DL2, and KIR3DL2 in Natural Killer Cells
di: Slawomir Chrul, et al.
Pubblicazione: (2006-01-01)

Killer Ig-like receptor (KIR) genotype and HLA ligand combinations in ulcerative colitis susceptibility.
di: Jones, D, et al.
Pubblicazione: (2006)

Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation
di: Daniela Pende, et al.
Pubblicazione: (2019-05-01)

Detection of a novel killer-cell immunoglobulin-like receptor allele - KIR3DL1*0150207 - in Asian individuals
di: Wang, L, et al.
Pubblicazione: (2014)

Detection of a novel killer-cell immunoglobulin-like receptor allele - KIR3DL1*0150207 - in Asian individuals.
di: Wang, L, et al.
Pubblicazione: (2014)

The KIRs of HLA-B27: the role of HLA-B27 KIR interactions in infection and spondyloarthritis
di: Wong-Baeza, I, et al.
Pubblicazione: (2011)

A proinflammatory response is mediated by synovial fibroblast and natural killer cell interaction in rheumatoid arthritis and spondyloarthritis
di: Chan, A, et al.
Pubblicazione: (2008)

A relevância das células natural killer (NK) e killer immunoglobulin-like receptors (KIR) no transplante de células-tronco hematopoéticas (TCTH) The relevance of natural killer (NK) cells and killer immunoglobulin-like receptors (KIR) in hematopoietic stem cell transplantation (HSCT)
di: Aline Almeida-Oliveira, et al.
Pubblicazione: (2008-08-01)

Expression of killer cell immunoglobulin-like receptors (KIR) in sex-associated malignancies
di: Hassan, Norfarazieda, et al.
Pubblicazione: (2022)

Killer-Cell Immunoglobulin-Like Receptors (KIR) in HIV-Exposed Infants in Cameroon
di: Kagoué Simeni Luc-Aimé, et al.
Pubblicazione: (2021-01-01)

Genomic full length sequence of a novel killer-cell immunoglobulin-like receptor, KIR3DL1*0010103 identified by sequencing.
di: Yindom, L, et al.
Pubblicazione: (2014)

A new variant of killer-cell immunoglobulin-like receptor KIR3DL1*03101 isolated using sequence-based techniques.
di: Yindom, L, et al.
Pubblicazione: (2014)

KIR3DL2 INTERACTION WITH HLA-B27 PROMOTES THE SURVIVAL OF TH17 CELLS IN ANKYLOSING SPONDYLITIS
di: Kollnberger, S, et al.
Pubblicazione: (2010)

Enhanced Expression of KIR3DL2 in Natural Killer and CD3/CD4 Positive T Cells of Ankylosing Spondylitis Patients Compared to HLA-B*2705 or B*2709 Healthy Subjects
di: Cauli, A, et al.
Pubblicazione: (2011)

Ligand specificity of Killer cell Immunoglobulin-like Receptors: a brief history of KIR
di: Jeroen eVan Bergen, et al.
Pubblicazione: (2012-12-01)

Interaction of HLA-B27 homodimers with KIR3DL1 and KIR3DL2, unlike HLA-B27 heterotrimers, is independent of the sequence of bound peptide.
di: Kollnberger, S, et al.
Pubblicazione: (2007)

Th17 cells expressing KIR3DL2+are increased in ankylosing spondylitis
di: Ridley, A, et al.
Pubblicazione: (2010)

KIR3DL2 INTERACTION WITH HLA-B27 PROMOTES THE SURVIVAL OF TH17 CELLS IN ANKYLOSING SPONDYLITIS
di: Kollnberger, S, et al.
Pubblicazione: (2010)

HLA-F and MHC-I Open Conformers Bind Natural Killer Cell Ig-Like Receptor KIR3DS1.
di: Aura Burian, et al.
Pubblicazione: (2016-01-01)

Lack of expression of inhibitory KIR3DL1 receptor in patients with natural killer cell-type lymphoproliferative disease of granular lymphocytes
di: Cristina Gattazzo, et al.
Pubblicazione: (2010-10-01)

Killer cell immunoglobulin-like receptor (KIR) genes and their HLA ligands in a Brazilian population
di: Daniela Maira Cardozo, et al.
Pubblicazione: (2023-07-01)

HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute ischemic stroke
di: Antonino Tuttolomondo, et al.
Pubblicazione: (2019-04-01)